Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2017

Aug 28, 2017

35221_dirs_2017-08-28_3e1eae2b-f96e-4644-830a-d267773b5a0a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2017-08-24

Reporting Person: MCGRATH DENNIS M (EVP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-24 Common Stock P 500 $4.1743 Acquired 9500 Indirect
2017-08-24 Common Stock P 500 $4.188 Acquired 10000 Indirect
2017-08-24 Common Stock P 500 $4.2399 Acquired 10500 Indirect
2017-08-24 Common Stock P 500 $4.242 Acquired 11000 Indirect
2017-08-24 Common Stock P 1000 $4.2429 Acquired 12000 Indirect